EP2303268 - PHARMACEUTICAL COMPOSITIONS BASED ON KININ B2 RECEPTOR ANTAGONISTS AND CORTICOSTEROIDS, AND THEIR USE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 26.04.2013 Database last updated on 18.11.2024 | Most recent event Tooltip | 27.04.2018 | Change - lapse in a contracting state State(s) deleted from list of lapses: CY | published on 30.05.2018 [2018/22] | Applicant(s) | For all designated states Istituto Luso Farmaco d'Italia S.p.A. Via Walter Tobagi, 8 20068 Peschiera Borromeo / IT | [2011/14] | Inventor(s) | 01 /
GIULIANI, Sandro Via Carlo Borrani 11 I-50012 Bagno A Ripoli (FI) / IT | 02 /
MAGGI, Carlo, Alberto Borgo Tegolaio 15 I-50125 Firenze / IT | [2011/14] | Representative(s) | Banfi, Paolo Bianchetti & Minoja with Trevisan & Cuonzo IPS Srl Via Plinio, 63 20129 Milano / IT | [N/P] |
Former [2012/25] | Banfi, Paolo Bianchetti Bracco Minoja S.r.l. Via Plinio, 63 20129 Milano / IT | ||
Former [2011/14] | Banfi, Paolo Bianchetti Bracco Minoja S.r.l. Via Plinio, 63 20129 Milano / IT | Application number, filing date | 09793880.7 | 03.07.2009 | [2011/14] | WO2009EP04847 | Priority number, date | IT2008MI01264 | 11.07.2008 Original published format: IT MI20081264 | [2011/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2010003601 | Date: | 14.01.2010 | Language: | EN | [2010/02] | Type: | A1 Application with search report | No.: | EP2303268 | Date: | 06.04.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.01.2010 takes the place of the publication of the European patent application. | [2011/14] | Type: | B1 Patent specification | No.: | EP2303268 | Date: | 20.06.2012 | Language: | EN | [2012/25] | Search report(s) | International search report - published on: | EP | 14.01.2010 | Classification | IPC: | A61K31/437, A61K31/4709, A61K31/496, A61K31/573, A61K38/08, A61P19/02 | [2011/14] | CPC: |
A61K31/573 (EP,KR,US);
A61K31/437 (EP,KR,US);
A61K31/4709 (EP,KR,US);
A61K31/496 (EP,KR,US);
A61P11/00 (EP);
A61P11/02 (EP);
A61P11/06 (EP);
A61P11/08 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/04 (EP);
A61P17/06 (EP);
A61P19/00 (EP);
A61P19/02 (EP);
A61P19/08 (EP);
A61P27/02 (EP);
A61P27/14 (EP);
A61P29/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2011/14] | Extension states | AL | 03.01.2011 | BA | 03.01.2011 | RS | 03.01.2011 | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN AUF BASIS VON KININ-B2-REZEPTORANTAGONISTEN UND CORTICOSTEROIDEN SOWIE IHRE VERWENDUNG | [2012/03] | English: | PHARMACEUTICAL COMPOSITIONS BASED ON KININ B2 RECEPTOR ANTAGONISTS AND CORTICOSTEROIDS, AND THEIR USE | [2011/14] | French: | COMPOSITIONS PHARMACEUTIQUES À BASE D ANTAGONISTES DU RÉCEPTEUR B2 DE LA KININE ET DE CORTICOSTÉROÏDES ET LEUR UTILISATION | [2011/14] |
Former [2011/14] | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN AUS BASIS VON KININ-B2-REZEPTORANTAGONISTEN UND CORTICOSTEROIDEN SOWIE IHRE VERWENDUNG | Entry into regional phase | 03.01.2011 | National basic fee paid | 03.01.2011 | Designation fee(s) paid | 03.01.2011 | Examination fee paid | Examination procedure | 23.03.2010 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 03.01.2011 | Examination requested [2011/14] | 28.12.2011 | Communication of intention to grant the patent | 29.03.2012 | Fee for grant paid | 29.03.2012 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 28.12.2011 | Opposition(s) | 21.03.2013 | No opposition filed within time limit [2013/22] | Fees paid | Renewal fee | 25.07.2011 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | SM | 20.06.2012 | MC | 31.07.2012 | [2018/22] |
Former [2018/17] | CY | 20.06.2012 | |
SM | 20.06.2012 | ||
MC | 31.07.2012 | ||
Former [2016/35] | CY | 20.06.2012 | |
SM | 20.06.2012 | ||
MC | 31.07.2012 | ||
Former [2014/27] | CY | 20.06.2012 | |
SM | 20.06.2012 | ||
MC | 31.07.2012 | ||
Former [2013/11] | CY | 20.06.2012 | |
MC | 31.07.2012 | ||
Former [2013/10] | CY | 20.06.2012 | Cited in | International search | [A]WO03000696 (METAPHORE PHARMACEUTICALS INC [US], et al) [A] * claims 23-26 *; | [A]WO2004069266 (AVENTIS PHARMA GMBH [DE]) [A] * page 1, paragraph 1 * * page 7, paragraph 3 *; | [A]WO2006040004 (LUSO FARMACO INST [IT], et al); | [A]WO2007003411 (JERINI AG [DE], et al) [A] * claims 4,5 *; | [X]EP1894559 (PARI PHARMA GMBH [DE]) [X] 1-8,10,11 * claims 19,20,40 *; | [A] - SHARMA, JAGDISH N. ET AL, "Inhibition of rats adjuvant arthritis by a bradykinin antagonist Hoe 140 and its influence on kallikreins", GENERAL PHARMACOLOGY , 27(1), 133-6 CODEN: GEPHDP; ISSN: 0306-3623, (1996), XP008105253 [A] * figure 1 * * page 135, column 2, paragraph 5 * DOI: http://dx.doi.org/10.1016/0306-3623(95)00078-X |